STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $142,000 | +21.4% | 12,755 | 0.0% | 0.00% | – |
| Q2 2017 | $117,000 | +14.7% | 12,755 | +7.2% | 0.00% | – |
| Q1 2017 | $102,000 | -13.6% | 11,900 | +7.8% | 0.00% | – |
| Q4 2016 | $118,000 | -1.7% | 11,042 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $120,000 | -21.1% | 11,042 | -50.7% | 0.00% | 0.0% |
| Q2 2016 | $152,000 | +63.4% | 22,395 | +63.2% | 0.00% | – |
| Q1 2016 | $93,000 | +45.3% | 13,725 | +34.8% | 0.00% | – |
| Q4 2015 | $64,000 | -28.9% | 10,185 | 0.0% | 0.00% | – |
| Q3 2015 | $90,000 | -25.0% | 10,185 | 0.0% | 0.00% | – |
| Q2 2015 | $120,000 | -74.1% | 10,185 | -68.1% | 0.00% | -100.0% |
| Q1 2015 | $463,000 | +202.6% | 31,974 | +256.5% | 0.00% | +100.0% |
| Q4 2014 | $153,000 | +36.6% | 8,968 | 0.0% | 0.00% | – |
| Q3 2014 | $112,000 | -13.2% | 8,968 | +1.9% | 0.00% | -100.0% |
| Q2 2014 | $129,000 | -15.1% | 8,798 | +17.8% | 0.00% | 0.0% |
| Q1 2014 | $152,000 | +4.1% | 7,467 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $146,000 | -55.8% | 7,467 | +2.3% | 0.00% | 0.0% |
| Q3 2013 | $330,000 | +371.4% | 7,297 | +149.1% | 0.00% | – |
| Q2 2013 | $70,000 | – | 2,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|